Industry Reflects on AI Drug Discovery Bottlenecks and Overpromises

Experts are reflecting on the overpromises of the AI drug discovery industry, noting that the real bottleneck to curing diseases isn't algorithms but the availability of clinical trial data. The sector's grand narrative of curing all diseases in a decade is currently hindered by data accessibility.

2026-07-28 ~ 2026-07-30 · 2 related posts

• AI in Pharma Faces Reality: Intelligence Isn't the Only Bottleneck — anshulkundaje · 2026-07-28
• What AI Really Needs to Cure Diseases: Boring Policy Answers — scottleibrand · 2026-07-30